News stories about "Novartis" in India.

Novartis lifts 2023 earnings forecast for third time

Switzerland's Novartis (NOVN.S) on Tuesday raised its full-year earnings forecast for the third time, citing cost cuts and higher-than-forecast prices for a multiple sclerosis (MS) drug. Key Points

Reuters

Novartis' Sandoz valued at $11.2 bln in market debut

Sandoz (SDZ.S) made its market debut with a lower-than-expected valuation of 10.3 billion Swiss francs ($11.2 billion) on Wednesday, after the generic and biosimilar drugmaker was spun off from Swiss pharmaceutical company Novartis (NOVN.S). Key Points

Reuters

Novartis raises sales growth target to 5% a year through 2027

Novartis (NOVN.S) has dialled up its sales growth target to 5% per year until 2027, citing demand for innovative drugs after the spin off of its generics business. Key Points

Reuters

Pharma stock recommends a final dividend of ₹10 and a one-time special dividend of ₹37.50: Do you own?

During today's closing session, the market capitalization of Novartis India, a small-cap pharmaceutical business, was ₹1,650.09 Cr. Key Points

mint

Novartis sues US government over Medicare drug price regulation

Swiss drugmaker Novartis (NOVN.S) on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure medicine Entresto. Key Points

Reuters